Detalles de la búsqueda
1.
A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration.
Pharmacogenet Genomics
; 26(1): 20-7, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26426212
2.
Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Ophthalmology
; 121(4): 905-10, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24365177
3.
Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration.
Mol Vis
; 18: 2271-8, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22933840
4.
Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
Ophthalmology
; 119(2): 339-46, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22133792
5.
Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.
Ophthalmology
; 119(11): 2304-11, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22840423
6.
Diagnostic analysis of the highly complex OPN1LW/OPN1MW gene cluster using long-read sequencing and MLPA.
NPJ Genom Med
; 7(1): 65, 2022 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36351915
7.
Complement Activation Levels Are Related to Disease Stage in AMD.
Invest Ophthalmol Vis Sci
; 61(3): 18, 2020 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32176267
8.
GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration.
Sci Rep
; 6: 37924, 2016 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27892514
9.
Association of Smoking and CFH and ARMS2 Risk Variants With Younger Age at Onset of Neovascular Age-Related Macular Degeneration.
JAMA Ophthalmol
; 133(5): 533-41, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25695752
10.
Predicting non-response to ranibizumab in patients with neovascular age-related macular degeneration.
Ophthalmic Epidemiol
; 21(6): 347-55, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25157998
11.
Zinc supplementation inhibits complement activation in age-related macular degeneration.
PLoS One
; 9(11): e112682, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25393287
12.
A functional variant in the CFI gene confers a high risk of age-related macular degeneration.
Nat Genet
; 45(7): 813-7, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23685748
13.
Short-term changes of Basal laminar drusen on spectral-domain optical coherence tomography.
Am J Ophthalmol
; 154(3): 560-7, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22626619
14.
Genetic, behavioral, and sociodemographic risk factors for second eye progression in age-related macular degeneration.
Invest Ophthalmol Vis Sci
; 53(9): 5846-52, 2012 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-22815349
15.
Clinical evaluation of 3 families with basal laminar drusen caused by novel mutations in the complement factor H gene.
Arch Ophthalmol
; 130(8): 1038-47, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22491393
16.
Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration.
Invest Ophthalmol Vis Sci
; 52(8): 5525-8, 2011 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21613373
17.
Central areolar choroidal dystrophy (CACD) and age-related macular degeneration (AMD): differentiating characteristics in multimodal imaging.
Invest Ophthalmol Vis Sci
; 52(12): 8908-18, 2011 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22003107
Resultados
1 -
17
de 17
1
Próxima >
>>